Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | PTC Therapeutics, Inc. PTCT |
BLACKROCK INC BLK |
6,274,384 8.000% |
-1,394,487 (-18.18%) |
Filing History |
| 2025-02-14 5:18 pm Sale |
2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
Armistice Capital, LLC | 6,378,000 8.270% |
-856,898 (-11.84%) |
Filing History |
| 2025-02-14 08:35 am Sale |
2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
Camber Capital Management LP | 3,200,000 4.150% |
-800,000 (-20.00%) |
Filing History |
| 2025-02-10 10:25 am Sale |
2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 4,787,123 6.200% |
-3,105,676 (-39.35%) |
Filing History |
| 2024-11-14 5:22 pm Purchase |
2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT |
Armistice Capital, LLC | 7,234,898 9.400% |
370,898 (+5.40%) |
Filing History |
| 2024-11-08 10:52 am Sale |
2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 7,892,799 10.260% |
-1,923,804 (-19.60%) |
Filing History |
| 2024-10-18 10:57 am Sale |
2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT |
STATE STREET CORP STT |
2,899,040 3.800% |
-1,734,915 (-37.44%) |
Filing History |
| 2024-08-27 4:45 pm Sale |
2024-08-23 | 13D | MRI INTERVENTIONS INC MRIC |
PTC THERAPEUTICS INC. PTCT |
894,578 3.240% |
-1,666,667 (-65.07%) |
Filing History |
| 2024-02-14 3:50 pm Purchase |
2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
Armistice Capital, LLC | 6,864,000 9.100% |
6,864,000 (New Position) |
Filing History |
| 2024-02-14 07:13 am Purchase |
2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 7,423,970 9.800% |
1,808,583 (+32.21%) |
Filing History |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | PTC Therapeutics, Inc. PTCT |
The Vanguard Group | 8,800,843 11.660% |
1,461,323 (+19.91%) |
Filing History |
| 2024-02-08 10:17 am Purchase |
2023-12-29 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 9,816,603 13.010% |
2,385,696 (+32.11%) |
Filing History |
| 2024-01-24 1:11 pm Purchase |
2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
STATE STREET CORP STT |
4,633,955 6.140% |
2,235,641 (+93.22%) |
Filing History |
| 2024-01-10 08:53 am Sale |
2024-01-09 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 1,814,421 2.404% |
-4,617,429 (-71.79%) |
Filing History |
| 2024-01-08 4:35 pm Purchase |
2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
BLACKROCK INC BLK |
7,668,871 10.200% |
1,028,017 (+15.48%) |
Filing History |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 6,431,850 8.523% |
-4,350,456 (-40.35%) |
Filing History |
| 2023-10-30 09:05 am Purchase |
2023-10-19 | 13G | PTC Therapeutics, Inc. PTCT |
Camber Capital Management LP | 4,000,000 5.310% |
4,000,000 (New Position) |
Filing History |
| 2023-06-15 4:41 pm Sale |
2023-06-13 | 13D | MRI INTERVENTIONS INC MRIC |
PTC THERAPEUTICS INC. PTCT |
2,561,245 9.760% |
-400,000 (-13.51%) |
Filing History |
| 2023-02-14 10:02 am Purchase |
2022-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW Investments, LP | 5,615,387 7.700% |
321,421 (+6.07%) |
Filing History |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | PTC Therapeutics, Inc. PTCT |
FMR CORP | 10,782,306 14.999% |
177,621 (+1.67%) |
Filing History |